TCE is a typical application of bsAbs, with one targeting arm of most TCEs designed to bind specifically to selected tumor-associated antigen (TAA) on the surface of tumor cells and the other targeting arm designed to target the CD3ε chain in the TCR complex. The gene discussed is CD3E; the disease is neoplasm.